|
|
|
SCHEDULE 14A
|
|
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. ) |
|
Filed by the Registrant ⌧
|
|
|
|
|
|
Filed by a Party other than the Registrant ☐
|
|
|
|
|
|
Check the appropriate box:
|
|
|
|
|
|
☐
|
Preliminary Proxy Statement
|
|
|
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☐
|
Definitive Proxy Statement
|
|
|
|
|
⌧
|
Definitive Additional Materials
|
|
|
|
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
|
|
|
|
IRADIMED CORPORATION
|
|
|
(Name of Registrant as Specified In Its Charter)
|
|
|
|
|
|
N/A
|
|
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
|
Payment of Filing Fee (Check all boxes that apply):
|
|
|
|
|
|
⌧
|
No fee required.
|
|
|
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
|
|
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|